Evidence-based practice to assist women in hospital settings to quit smoking and reduce cardiovascular disease risk

Journal of Cardiovascular Nursing

Volumn 23, Issue 5, 2008, Pages 397-406

  Buchanan, Lynne ^a   Likness, Sheila ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Cardiovascular risk reduction; Relapse prevention in women; Smoking cessation; Weight management

Indexed keywords

BIOLOGICAL MARKER; COTININE; NICOTINE; NICOTINIC AGENT;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; CHEMISTRY; DEPRESSION; EVIDENCE BASED MEDICINE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INTRADERMAL DRUG ADMINISTRATION; METABOLISM; METHODOLOGY; OBESITY; PATIENT SATISFACTION; PILOT STUDY; SALIVA; SELF CONCEPT; SMOKING CESSATION; SOCIAL SUPPORT; TREATMENT OUTCOME; WITHDRAWAL SYNDROME; WOMEN'S HEALTH;

ADMINISTRATION, CUTANEOUS; ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COTININE; DEPRESSION; EVIDENCE-BASED MEDICINE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; NICOTINE; NICOTINIC AGONISTS; OVERWEIGHT; PATIENT SATISFACTION; PILOT PROJECTS; SALIVA; SELF EFFICACY; SMOKING CESSATION; SOCIAL SUPPORT; SUBSTANCE WITHDRAWAL SYNDROME; TREATMENT OUTCOME; WOMEN'S HEALTH;

EID: 56049087325     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/01.JCN.0000317449.87649.8e     Document Type: Article

References (37)

1. Craig JV, Smyth RL. The Evidence Based Practice Manual for Nurses. 2nd ed. New York, NY: Churchill Livingston Elsevier; 2007.
2. Ridker P, Buring J, Rifai N, Cook N. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women. JAMA. 2007;297:6.
3. US Department of Health and Human Services, Surgeon General Report. Smoking and Health. A Report of the Surgeon General. Washington, DC: US Department of Health and Human Services; 2004.
4. Fiore MC, Bailey WC, Cohen SJ. Treating tobacco use and dependence. In: Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services; 2000.
5. Agency for Health Care Research. Quit Smoking: Consumer Interactive Tool (PED/Palm). Rockville, MD: Agency for Healthcare Research and Quality (AHRQ); 2004. Downloads from the AHRQ Web site. http://pda.ahrq.gov/ consumer/qscit/qscit.htm. Accessed November 28, 2007.
6. Buchanan L, El-Banna M, Siedlik C, White A, Wood M. An exploratory study of multicomponent treatment intervention for tobacco dependency. Image J Nurs Scholarsh. 2004;36(4):324-330.
7. Chandola T, Head J, Bartley M. Socio-demographic predictors of quitting smoking: how important are household factors? Addiction. 2004;99(6):770-774.
8. Glassman A, Covey L, Stetner F, Rivelli S. Smoking cessation and the course of major depression: a follow-up study. Lancet. 2001;357:1929-1932.
9. Delfino RJ, Jamner LD, Whalen CK. Temporal analysis of the relationship of smoking behavior and urges to mood states in men versus women. Nicotine Tob Res. 2001;3(3): 235-248.
10. Filozof C, Fernandez P, Fernandez-Cruz A. Smoking cessation and weight gain. Obesity Rev. 2004;5(2):95-103.
11. Park E-W, Schultz JK, Tudiver F, Campbell T, Becker L. Enhancing partner support to improve smoking cessation. Cochrane Database of Systematic Reviews. 2002; Issue 1, Art. No.: CD002928. DOI: 10.1002/14651858.CD002928. pub2.
12. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319:1318-1330.
13. Silagy C, Lancaster T, Stead L, Mant D, Fowler F. Nicotine replacement therapy for cessation. Cochrane Database Syst Rev. 2004; Issue 3: CD000146/14651858. CD000146.pub2.
14. Jorenby DE, Hays JT, Rigotti NA, et al. Efficacy of varenicline, an a4b2 nicotinic acetylcholine receptor partial agonist vs placebo or sustained release bupropion for smoking cessation. JAMA. 2006;296(1):56-62.
15. Uphold C, Graham M. Clinical guidelines in adult health. Gainesville, FL: Barmarrae Books, Inc; 2003:83.
16. Bandura A. Self-efficacy: The Exercise of Control. New York, NY: Freeman; 1997.
17. Stead LF, Perera R, Lancaster T. Telephone counseling for smoking cessation. Cochrane Database of Systematic Reviews. 2001; Issue 2, Art. No.: CD002850. DOI:10. 1002/14651858.CD002850.pub2.
18. Taylor C, Houston Miller N, Killen J, DeBusk R. Smoking cessation after acute myocardial infarction: effects of a nurse managed intervention. Ann Intern Med. 1990;113:118-123.
19. Taylor C, Houston-Miller N, Herman S, et al. A nursemanaged smoking cessation program for hospitalized smokers. Am J Public Health. 1996;86:1557-1560.
20. Sivarajan Froelicher E, Christophersohn D, Miller N, Martin K. Women's initiative for nonsmoking, IV: description of 227 women smokers hospitalized with cardiovascular disease. Heart Lung. 2002;31(1):3-14.
21. Chouinard MC, Robichaud-Ekstrand S. The effectiveness of a nursing inpatient smoking cessation program in individuals with cardiovascular disease. Nurs Res. 2005;54(4):243.
22. Heatherton T, Kozplowski L, Frecke R, Fagerstrom K. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict. 1991;36:1119-1127.
23. Pomerleau C, Solange C, Lutzke K, Flessand K, Pomerleau O. Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addict Behav. 1994;19:33-39.
24. Chabrol H, Niezborala M, Chastan E, Montastrue J, Mullet E. A study of the psychometric properties of the Fagerstrom Test for Nicotine Dependence. Addict Behav. 2003;23:1441-1445.
25. Accutest NicAlert [package insert]. Encino, CA: Jant Phar-macal Corporation; 2005.
26. Etter JF, Vu Duc T, Perneger TV. Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol. 2000;151(3):251-258.
27. Coulehan JL, Schulberg HC, Block MR. The efficiency of depression questionnaires for case finding in primary medical care. J Intern Med. 1989;4:542-547.
28. Cohen S, Lichtenstein E. Partner behaviors that support quitting smoking. J Consult Clin Psychol. 1990;58(3):304-309.
29. Lichtenstein E, Glasgow R, Abrams D. Social support and smoking cessation: in search of effective interventions. Behav Ther. 1986;17:607-619.
30. Mermelstein R, Lichtenstein E, McIntyrem K. Partner support and smoking relapse in smoking cessation programs. J Consult Clin Psychol. 1983;51:465-466.
31. Pollak KI, McBride CM, Baucom DH, et al. Women's perceived and partners' reported support for smoking cessation during pregnancy. Ann Behav Med. 2001;23:208-214.
32. Velicer WF, Diclemente CC, Rossi JS. Relapse situations and self-efficacy. An integrative model. Addict Behav. 1990;15:271-283.
33. Stoffelmayr B. An examination of the process of relapse prevention therapy designed to aid smoking cessation. Addict Behav. 2003;28(7):1351-1358.
34. Etter JF, Perneger TV. Effectiveness of a computer-tailored smoking cessation program: a randomized trial. Arch Intern Med. 2001;161(21):2596-2601.
35. Davis FD. Perceived usefulness, perceived ease of use, and user acceptance of information technology. MIS Q. 1989;12(3): 319-340.
36. Venkatesh V, Davis FD. A theoretical extension of the technology acceptance model: four longitudinal field studies. Manage Sci. 2000;46:2186-2204.
37. Venkatesh V, Morris MG, Davis GB, Davis FD. User acceptance of information technology: toward a unified view. MIS Q. 2003;27(3):425-478.